Pulmonary Arteyr Denervation for HF Without PH

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

May 1, 2025

Conditions
Heart Failure
Interventions
DEVICE

Pulmonary artery denervation (PADN)

Combining invasive angiography with pulmonary artery CTA is frequently employed to determine the final size of the PADN catheter, aiming for an expected ratio of distal ring/vessel diameter between 1.1 and 1.2. The PADN system comprises a radiofrequency generator, connecting tubing and control handle, and the PADN catheter. The main interface of the radiofrequency generator offers multiple language options and displays parameters such as temperature, impedance, energy, and ablation time. The generator features three control modes: temperature control, power control, and a combination of both.

Trial Locations (1)

210006

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06323512 - Pulmonary Arteyr Denervation for HF Without PH | Biotech Hunter | Biotech Hunter